Journal
AUSTRALASIAN PSYCHIATRY
Volume 23, Issue 4, Pages 361-364Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1039856215591327
Keywords
body dysmorphic disorder; MRI; faces
Categories
Funding
- Eli Lilly
- Janssen Cilag
- Roche
- Allergen
- Bristol-Myers Squibb
- Pfizer
- Lundbeck
- Astra Zeneca
- Hospira
Ask authors/readers for more resources
Objectives: We aim to provide a clinically focused review of the neurobiological literature in body dysmorphic disorder (BDD), with a focus on structural and functional neuroimaging. Conclusions: There has been a recent influx of studies examining the underlying neurobiology of BDD using structural and functional neuroimaging methods. Despite obvious symptom similarities with obsessive-compulsive disorder (OCD), no study to date has directly compared the two groups using neuroimaging techniques. Studies have established that there are limbic and visual cortex abnormalities in BDD, in contrast to fronto-striatal differences in OCD. Such data suggests affect or visual training maybe useful in BDD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available